NSWRC(SH:600165) Xin Lang Cai Jing·2025-12-25 23:53Core Viewpoint - Investors affected by the false statements of Ningxia Zhongke Biological Technology Co., Ltd. can register for compensation through the Sina Investor Rights Protection Platform, as some investors have already received compensation [1][2]. Group 1: Legal Proceedings and Violations - On June 1, 2023, the company announced it received a warning letter from the Ningxia Securities Regulatory Bureau due to issues such as failure to timely disclose the progress of a subsidiary's capital increase plan and significant litigation matters [5]. - On October 30, 2024, the company and its actual controller, Mr. Yu Jianming, received a notice of investigation from the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [5]. - On February 14, 2025, the company and Mr. Yu received a notice of administrative penalty from the Ningxia Regulatory Bureau, followed by an administrative penalty decision on April 4, 2025, confirming violations including false records in the 2022 annual report and failure to disclose significant events in a timely manner [5]. Group 2: Compensation Eligibility - Investors who purchased shares between November 22, 2022, and April 5, 2023, and held them regardless of whether they sold after April 6, 2023, or those who bought between April 28, 2023, and October 30, 2024, and held them regardless of whether they sold after October 31, 2024, may be eligible for compensation [3][6].